Back to School: How biopharma can reboot drug development. Access exclusive analysis here

4SC cancer news

4SC will reduce headcount by 13 (15%) to 71 and close its Uberlingen-Bonndorf, Germany, office this year as it implements changes announced earlier this year. The company said the cuts will come mainly

Read the full 333 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE